However, as described previously, SFRP1 expression was associated with luminal breast cancer outcomes specifically, expressing ERα and/or PR, corroborating the existence of a crosstalk between the Wnt signaling pathway and the ERα signaling pathway during breast carcinogenesis. Here, SFRP1 is linked to breast cancer.